Tempus AI, Inc. $TEM Stock Holdings Boosted by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lifted its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 707.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,716 shares of the company's stock after purchasing an additional 4,132 shares during the period. PNC Financial Services Group Inc.'s holdings in Tempus AI were worth $228,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. ARK Investment Management LLC lifted its position in shares of Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock worth $361,867,000 after purchasing an additional 1,981,755 shares in the last quarter. Nikko Asset Management Americas Inc. lifted its position in shares of Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock worth $205,401,000 after purchasing an additional 1,021,460 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after purchasing an additional 1,016,384 shares in the last quarter. Frontier Capital Management Co. LLC lifted its position in shares of Tempus AI by 236.2% during the fourth quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company's stock worth $31,860,000 after purchasing an additional 663,018 shares in the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new position in shares of Tempus AI during the first quarter worth $34,119,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on TEM. Bank of America boosted their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Needham & Company LLC reissued a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. BTIG Research upped their price target on shares of Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Morgan Stanley upped their price target on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a report on Tuesday, August 12th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $67.64.

Tempus AI Stock Performance

Shares of NASDAQ:TEM traded up $3.43 on Thursday, reaching $76.71. 15,592,527 shares of the company's stock were exchanged, compared to its average volume of 11,130,016. The firm has a market capitalization of $13.33 billion, a price-to-earnings ratio of -64.46 and a beta of 4.98. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $91.45. The business's 50-day moving average is $63.59 and its two-hundred day moving average is $59.09. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The firm's revenue was up 89.5% compared to the same quarter last year. During the same period in the prior year, the company earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Activity at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 17,460 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the sale, the chief operating officer directly owned 839,180 shares of the company's stock, valued at approximately $62,644,787. This represents a 2.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO James William Rogers sold 7,528 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the sale, the chief financial officer directly owned 138,473 shares in the company, valued at $10,337,009.45. This trade represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 776,451 shares of company stock valued at $53,022,688 in the last ninety days. 27.60% of the stock is owned by insiders.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.